Abiraterone continues to reveal early but promising data in advanced prostate cancer http://bit.ly/a1mf0e $JNJ $CGRB

@downtowntrader $CGRB $MDVN , CYTK, $ARIA $IMGN

Crumbs, hot on the $JNJ $CGRB deal is $SNY $EXEL for PI3K inhibitors, all before ASCO. The licensing stakes are going up $$

$JNJ $CGRB new abiraterone data in prostate cancer is out ahead of ASCO http://bit.ly/eEzZT $$

In case you missed it, $CGRB roared higher Fri, after it agreed to be bought by $JNJ in a deal valued at $900 million. http://bit.ly/P3Tkk

Just back from the Memorial w/e away to discover I missed the $jnj $cgrb deal Wow $$

$cgrb

Rodman analyst: $OGXI drug ahead of $CGRB. $OGXI has shown survival benefit. $CGRB has only shown a PSA response http://tinyurl.com/q7ok38

RT @BigMovingStock: Friday May 22 2009 52 Week Highs $ISHG $BPI $IGOV $COT $GOLD $CGRB $NTES $PSAU $BDGE $OGXI $MYRG

Movers update ($CGRB, $DRM, $ADM) with @KevinBCook from the floor of @CMEGroup: http://bit.ly/Dd2AE

Anyone have a ratio spread on $CGRB ? Looks like someone wants a bit of protection from these gains http://bit.ly/V1gDD

$CGRB needed this buyout if only to consider a new name. Cougar?

Pre-market Most Active - $CGRB, $DRYS, $FITB, $QGEN, $MCHP http://bit.ly/NUdFQ #premarket #nasdaq

Big morning movers: $SHLD up 16.6%; $CGRB up 15.5%; $CRM down 9.5%